Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

FTSE 100 drugs company to become largest listed shareholder
Thursday 23 Mar 2017 Author: Daniel Coatsworth


FTSE 100 drugs giant AstraZeneca (AZN) is to become a 14.3% shareholder in small cap speciality pharma business Circassia (CIR). The latter is buying US commercial rights to two products from AstraZeneca in a cash and shares deal. AstraZeneca will displace Touchstone Innovations (IVO) as the biggest listed shareholder; Touchstone presently owns 9.3% of Circassia, according to Reuters. (DC)

‹ Previous2017-03-23Next ›